TripleBlind was founded with the mission to provide scalable, software-only privacy solutions that enhance data security and compliance. The company focuses on healthcare and financial services, offering products like Privacy Suite and SecuriKey, which enable HIPAA-compliant data sharing and cryptographically secure privacy. TripleBlind leverages principles such as federated learning and multi-party computation to address a broad range of use cases, ensuring robust protection against data breaches and unauthorized access.
TripleBlind is backed by notable investors including Accenture, General Catalyst, and The Mayo Clinic. The company has achieved significant milestones in developing quantum-safe and cryptographically secure software, positioning itself as a leader in privacy-enhancing computation. Its impact is evident in its ability to provide secure data solutions that comply with stringent regulations, thereby fostering trust and security in digital interactions across critical sectors.
